Navigation Links
CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
Date:10/7/2010

WOONSOCKET, R.I., Oct. 7 /PRNewswire-FirstCall/ -- CVS Caremark (NYSE: CVS) announced today that it has appointed Jonathan C. Roberts as Chief Operating Officer of its pharmacy benefit management business.  Roberts, who is currently Executive Vice President, Rx Purchasing, Pricing and Network Relations, will now also assume the leadership of PBM operations, mail service pharmacy and specialty pharmacy.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO)

"Jon is the ideal candidate to fill this newly created role within the PBM," said Per Lofberg, President, Pharmacy Benefit Management, CVS Caremark.  "His broad base of pharmacy experience will further our mission to continually improve how we do business and look for ways to do it better, more efficiently and at a lower cost."

Roberts, 54, is an experienced health care executive and pharmacist.  He joined CVS/pharmacy nearly 20 years ago and has served in a variety of leadership roles across the enterprise including Senior Vice President, Store Operations, CVS/pharmacy and Chief Information Officer, CVS Caremark.  Roberts earned his degree in pharmacy from the Virginia Commonwealth University School of Pharmacy.

"Jon has spearheaded numerous initiatives over the years that have enhanced our delivery of pharmacy care," added Thomas M. Ryan, Chairman and CEO, CVS Caremark.  "I am confident that in this newly expanded role Jon will support our PBM growth strategy and overall longer-term success."

About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access, to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including approximately 7,100 CVS/pharmacy stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com.Media Contact:  Eileen Howard DunnSenior Vice PresidentCorporate Communications(401) 770-4561Investor Contact:Nancy ChristalSenior Vice PresidentInvestor Relations(914) 722-4704
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year
2. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
3. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
4. CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October
5. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
6. CVS Caremark Announces Updates to Flu Vaccine Program
7. CVS Caremarks MinuteClinic and Allina Hospitals & Clinics Form Strategic Partnership
8. CVS Caremark Corporation Increases Quarterly Dividend 15%
9. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
10. CVS Caremark Names New Chief Human Resources Officer
11. CVS Caremark Corporation Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):